344
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Survival with Tiotropium Compared to Long-Acting Beta-2-Agonists in Chronic Obstructive Pulmonary Disease

, , , &
Pages 229-234 | Published online: 02 Jul 2009

REFERENCES

  • Celli B R, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23(6)932–946
  • Global Initiative for Chronic Obstructive Pulmonary Disease. National Institutes of Health, National Heart, Lung and Blood Institute, Bethesda, MD 2005, Workshop Report, Global Strategy for Diagnosis, Management, and Prevention of COPD. Update Sept.
  • National Institutes of Health NHLaBI. Morbidity and Mortality: 2004 Chart Book on cardiovascular, lung, and blood diseases. U.S. Department of Health and Human Services. 2004
  • Naunheim K S, Wood D E, Mohsenifar Z, Sternberg A L, Criner G J, DeCamp M M, et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006; 82(2)431–443
  • Barr R G, Bourbeau J, Camargo C A, Ram F S. Inhaled tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005, (2):CD002876
  • O'Donnell D E, Aaron S, Bourbeau J, Hernandez P, Marciniuk D, Balter M, et al. State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. Can Respir J 2004; 11(Suppl B)7B–59B
  • Aaron S D, Vandemheen K L, Fergusson D, Maltais F, Bourbeau J, Goldstein R, et al. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: A randomized trial. Ann Intern Med 2007
  • Decramer M, Celli B, Tashkin D P, Pauwels R A, Burkhart D, Cassino C, et al. Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial. COPD 2004; 1(2)303–312
  • Canadian Institute of Health Information. Data quality of the discharge abstract database following the first year implementation of ICD-10-CA/CCI - Final report. Canadian Institute of Health Information. 2004
  • Rawson N S, Malcolm E. Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles. Stat Med 1995; 14(24)2627–2643
  • Calverley P M, Anderson J A, Celli B, Ferguson G T, Jenkins C, Jones P W, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356(8)775–789
  • Charlson M E, Pompei P, Ales K L, MacKenzie C R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5)373–383
  • Deyo R A, Cherkin D C, Ciol M A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45(6)613–619
  • Sin D D, Tu J V. Are elderly patients with obstructive airway disease being prematurely discharged?. Am J Respir Crit Care Med 2000; 161(5)1513–1517
  • Salpeter S, Ormiston T, Salpeter E. Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005, (4):CD003566
  • PCCF+ Version 4D User's Guide (Geocodes/PCCF). Automated Geographic Coding Based on the Statistics Canada Postal Code Conversion Files. Statistics Canada, Ottawa 2004, Including Postal Codes to December 2003
  • Briggs D D, Jr., Covelli H, Lapidus R, Bhattycharya S, Kesten S, Cassino C. Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD. Pulm Pharmacol Ther 2005; 18(6)397–404
  • Hodder R, Kesten S, Menjoge S, Viel K. Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids. Int J Chron Obstruct Pulmon Dis 2007; 2(2)157–167
  • Salpeter S R, Buckley N S, Salpeter E E. Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD. J Gen Intern Med 2006; 21(10)1011–1019
  • Breekveldt-Postma N S, Koerselman J, Erkens J A, Lammers J W, Herings R M. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Respir Med 2007; 101(7)1398–1405
  • Walters E, Gibson P, Lasserson T, Walters J. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid. Cochrane Database Syst Rev 2007, (1):CD001385
  • Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003; 361(9356)449–456
  • Appleton S, Poole P, Smith B, Veale A, Lasserson T J, Chan M M. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; 3, CD001104
  • Stukel T A, Fisher E S, Wennberg D E, Alter D A, Gottlieb D J, Vermeulen M J. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007; 297(3)278–285
  • Zhou Z, Rahme E, Abrahamowicz M, Pilote L. Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods. Am J Epidemiol 2005; 162(10)1016–1023
  • Benson K, Hartz A J. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000; 342(25)1878–1886

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.